Table 2.
Chr | SNP | A1 * | A2 † | Freq ‡ | Gene | eQTLs § | Beta¶ | PGEE | PGEEλ # | PLME | Direction** |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | rs61776523 | A | G | 0.86 | Y_RNA | - | −0.51 | 5.99E-05 | 5.97E-05 | 6.28E-05 | +----x----++ |
2 | rs62146087 | A | G | 0.62 | CD8B | CD8B, PLGLB1 | 0.40 | 1.96E-05 | 2.47E-05 | 7.49E-05 | +++++++-+x-+ |
2 | rs10930401 | T | C | 0.88 | intergenic | METTL5 | −0.49 | 7.00E-05 | 6.85E-05 | 7.81E-05 | -------+--x- |
2 | rs11683533 | G | A | 0.63 | intergenic | - | −0.45 | 2.09E-06 | 6.50E-06 | 9.10E-05 | ---------+-- |
3 | rs1447793 | G | A | 0.95 | ROBO2 | - | 0.89 | 5.73E-05 | 1.19E-05 | 2.22E-05 | +x+++++x-+xx |
3 | rs79279449 | T | C | 0.84 | LSAMP | - | −0.48 | 2.54E-05 | 8.21E-05 | 1.77E-05 | -+--+------x |
3 | rs28853947 | C | T | 0.70 | RP11–384F7.1 | - | −0.45 | 2.29E-06 | 5.93E-07 | 8.59E-05 | --------+++x |
3 | rs4857800 | T | A | 0.65 | intergenic | - | −0.40 | 7.90E-06 | 1.03E-06 | 8.39E-05 | -----+----++ |
4 | rs12501599 | G | C | 0.78 | CLNK | ZNF518B | 0.46 | 1.34E-05 | 7.35E-05 | 2.42E-05 | ++++-+++++++ |
4 | rs2168075 | A | G | 0.45 | CCSER1 | CCSER1 | −0.37 | 4.62E-05 | 8.89E-05 | 9.38E-05 | --------+-+- |
4 | rs1304013 | C | T | 0.73 | intergenic | - | 0.50 | 4.73E-07 | 8.82E-06 | 2.48E-05 | -++++++x-+++ |
6 | rs9393409 | A | G | 0.36 | intergenic | - | −0.39 | 2.70E-05 | 1.81E-05 | 9.17E-05 | -----x++---+ |
6 | rs9380681 | T | C | 0.70 | intergenic | - | 0.46 | 1.40E-06 | 1.80E-06 | 3.09E-05 | ++++-++x-+-+ |
6 | rs45604140 | C | G | 0.90 | PTK7 | DNPH1, KLHDC3 | −0.54 | 6.07E-05 | 1.98E-05 | 7.15E-06 | -+----+---++ |
6 | rs4897203 | T | C | 0.09 | TRDN | - | 0.74 | 1.34E-06 | 2.14E-06 | 9.56E-07 | +++++++-+-++ |
7 | rs7806833 | T | G | 0.22 | SCIN | - | −0.46 | 4.99E-05 | 5.64E-05 | 4.44E-05 | ----------+- |
7 | rs39437 | G | C | 0.16 | OSBPL3-CYCS | - | 0.51 | 4.68E-06 | 2.15E-06 | 9.70E-05 | ++++++++-++- |
7 | rs17150563 | T | C | 0.72 | intergenic | HIBADH, TAX1BP1 | 0.40 | 6.08E-05 | 2.13E-05 | 3.61E-05 | ++-++++x-+-+ |
7 | rs7792776 | G | A | 0.87 | intergenic | - | −0.55 | 1.08E-05 | 1.68E-05 | 2.07E-05 | ----------+- |
7 | rs6959165 | A | G | 0.45 | HECW1 | - | 0.36 | 2.96E-05 | 1.82E-05 | 1.64E-05 | +++++++x--++ |
7 | rs60465337 | C | T | 0.97 | CNTNAP2 | - | 1.03 | 8.59E-07 | 4.06E-07 | 2.86E-05 | ++++++++++x- |
8 | rs16877878 | A | G | 0.96 | RP11–566H8.3 | - | 1.18 | 1.13E-05 | 9.35E-05 | 1.33E-05 | x+++++x++++x |
10 | rs182768834 | G | A | 0.95 | intergenic | - | −0.87 | 1.60E-06 | 9.96E-06 | 6.31E-05 | ----------x- |
11 | rs61897000 | G | A | 0.66 | CHRDL2 | XRRA1 | −0.36 | 7.25E-05 | 1.69E-05 | 6.44E-05 | --+-----+-++ |
12 | rs7301894 | A | G | 0.44 | ANO2 | - | −0.34 | 8.59E-05 | 6.21E-05 | 7.54E-05 | -------x+--+ |
12 | rs10785192 | T | A | 0.07 | RP11–585P4.5 | RP11–585P4.5, GLIPR1L2 | −0.69 | 2.23E-05 | 5.99E-05 | 1.69E-06 | --+--------x |
12 | rs660322 | G | A | 0.24 | TMEM132D | - | 0.53 | 1.07E-05 | 9.44E-06 | 1.14E-05 | x+-+++++-xx+ |
15 | rs2899492 | C | T | 0.16 | FAM214A | ARPP19 | 0.62 | 5.94E-07 | 9.70E-07 | 1.37E-05 | ++-++++x+xx+ |
15 | rs8041705 | T | C | 0.56 | HMGB1P8 | - | −0.41 | 1.76E-05 | 2.66E-05 | 2.22E-05 | -----x---x+- |
15 | rs12324317 | T | C | 0.61 | RLBP1 | RLBP1, POLG | −0.40 | 1.80E-05 | 2.11E-05 | 1.91E-05 | ----+-+x+-+- |
15 | rs9788714 | G | A | 0.62 | RLBP1-FANCI | POLG | −0.42 | 2.50E-06 | 1.70E-06 | 1.70E-06 | -----++-+-+x |
15 | rs2238301 | A | G | 0.61 | FANCI | POLG | −0.46 | 3.30E-07 | 1.59E-07 | 3.15E-07 | ------+-+-+x |
15 | rs3176205 | T | C | 0.61 | POLG | POLG | −0.46 | 2.75E-07 | 1.49E-07 | 1.11E-07 | -----++-+-+x |
16 | rs4949142 | A | G | 0.85 | intergenic | - | −0.60 | 5.83E-07 | 4.02E-07 | 7.82E-06 | -------x--x+ |
16 | rs12448088 | G | C | 0.40 | PLCG2 | - | −0.41 | 2.91E-05 | 2.36E-05 | 1.10E-05 | +---x----x-+ |
17 | rs2071194 | C | A | 0.36 | EVPL | TEN1 | 0.41 | 1.44E-05 | 3.84E-05 | 6.67E-05 | +++++++x-+++ |
effect allele,
other allele,
frequency of effect allele,
Expression Quantitative Trait Locus: genes differentially expressed by SNP genotype according to GTEx database,
beta from GEE model including all cohorts,
p-value from GEE model excluding cohorts with λ>1.2,
effect direction in individual cohorts from the GEE model including all cohorts. The order of the symbols is Pfizer, 3C, ADNI, Flurizan, NACC, ROS/MAP1, Semagacestat, ADNeuroMed, ACT, WashU, WHICAP, ROS/MAP2.